Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4

被引:46
作者
Haas, K
Johannes, C
Geisen, C
Schmidt, T
Karsunky, H
BlassKampmann, S
Obe, G
Moroy, T
机构
[1] UNIV ESSEN GESAMTHSCH KLINIKUM,IFZ,INST ZELLBIOL TUMORFORSCH,D-45172 ESSEN,GERMANY
[2] UNIV ESSEN GESAMTHSCH,GENET ABT,D-45172 ESSEN,GERMANY
关键词
cyclin E; malignant transformation; Myc; CDK inhibitors; polyploidy;
D O I
10.1038/sj.onc.1201434
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We demonstrate in this paper that the G1 phase specific cell cycle regulator cyclin E is able to provoke focus formation when cotransfected with activated Ha-ras into primary rat embryo fibroblasts (REFs). Cyclin E/Ha-ras transformed cells are highly tumorigenic in synergeneic rats, are able to form colonies in soft agar and show protection towards apoptosis upon serum starvation or DNA damage compared to cells transformed by the combination of Myc, cyclin D1 or SV40 large T-antigen and Ha-ras. Lines that were established after cyclin El Ha-ras or cyclin D1/Ha-ras transformation contain a large percentage of polyploid cells, This was not observed in cells transformed with other oncoproteins and Ha-ras pointing to an involvement of D-and E type cyclins in genomic instability. The cyclin dependent kinase inhibitors p21 and p27 but also p16 completely abrogate focus formation by cyclin E and Ha-ras suggesting that the oncogenic activity of cyclin E still requires functional G1 specific cyclin/CDK complexes. Moreover, inhibition of Myc function also blocks the oncogenic activity of cyclin E indicating a requirement of Myc for cyclin E function, The findings presented here demonstrate that cyclin E can act as an oncoprotein with a potential involvement in genomic instability and the prevention of cell death, Our data also present more evidence for a strict functional interdependency between G1 cyclin/CDK complexes and c-Myc.
引用
收藏
页码:2615 / 2623
页数:9
相关论文
共 54 条
[1]   The retinoblastoma protein pathway and the restriction point [J].
Bartek, J ;
Bartkova, J ;
Lukas, J .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) :805-814
[2]   INTERACTION OF C-MYC WITH THE PRB-RELATED PROTEIN P107 RESULTS IN INHIBITION OF C-MYC-MEDIATED TRANSACTIVATION [J].
BEIJERSBERGEN, RL ;
HIJMANS, EM ;
ZHU, L ;
BERNARDS, R .
EMBO JOURNAL, 1994, 13 (17) :4080-4086
[3]   REGULATION OF THE RETINOBLASTOMA PROTEIN-RELATED P107 BY G(1) CYCLIN COMPLEXES [J].
BEIJERSBERGEN, RL ;
CARLEE, L ;
KERKHOVEN, RM ;
BERNARDS, R .
GENES & DEVELOPMENT, 1995, 9 (11) :1340-1353
[4]   CYCLIN D1 TRANSGENE IMPEDES LYMPHOCYTE MATURATION AND COLLABORATES IN LYMPHOMAGENESIS WITH THE MYC GENE [J].
BODRUG, SE ;
WARNER, BJ ;
BATH, ML ;
LINDEMAN, GJ ;
HARRIS, AW ;
ADAMS, JM .
EMBO JOURNAL, 1994, 13 (09) :2124-2130
[5]   Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E [J].
Bortner, DM ;
Rosenberg, MP .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) :453-459
[6]  
Botz J, 1996, MOL CELL BIOL, V16, P3401
[7]   FEATURES OF APOPTOTIC CELLS MEASURED BY FLOW-CYTOMETRY [J].
DARZYNKIEWICZ, Z ;
BRUNO, S ;
DELBINO, G ;
GORCZYCA, W ;
HOTZ, MA ;
LASSOTA, P ;
TRAGANOS, F .
CYTOMETRY, 1992, 13 (08) :795-808
[8]   Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content [J].
Datta, NS ;
Williams, JL ;
Caldwell, J ;
Curry, AM ;
Ashcraft, EK ;
Long, MW .
MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (02) :209-223
[9]   Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc [J].
Desbarats, L ;
Gaubatz, S ;
Eilers, M .
GENES & DEVELOPMENT, 1996, 10 (04) :447-460
[10]   PHYSICAL INTERACTION OF THE RETINOBLASTOMA PROTEIN WITH HUMAN D-CYCLINS [J].
DOWDY, SF ;
HINDS, PW ;
LOUIE, K ;
REED, SI ;
ARNOLD, A ;
WEINBERG, RA .
CELL, 1993, 73 (03) :499-511